Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo
Artwork

Content provided by Keyvan Koushan, MD, and FRCSC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Keyvan Koushan, MD, and FRCSC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.
Player FM - Podcast App
Go offline with the Player FM app!

E70-Archway 3 Port Delivery System for wAMD- Dr. Carl Regillo

30:51
 
Share
 

Manage episode 372222470 series 2416620
Content provided by Keyvan Koushan, MD, and FRCSC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Keyvan Koushan, MD, and FRCSC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Dr. Regillo describes the results of the phase 3 prospective study of Ranibizumab Port Delivery System (PDS) for the treatment of neovascular AMD.

Reference Article:

Regillo C, Berger B, Brooks L, Clark WL, Mittra R, Wykoff CC, Callaway NF, DeGraaf S, Ding HT, Fung AE, Gune S, Le Pogam S, Smith R, Willis JR, Barteselli G. Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results. Ophthalmology. 2023 Jul;130(7):735-747. doi: 10.1016/j.ophtha.2023.02.024. Epub 2023 Mar 2. PMID: 36870451.

  continue reading

89 episodes

Artwork
iconShare
 
Manage episode 372222470 series 2416620
Content provided by Keyvan Koushan, MD, and FRCSC. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Keyvan Koushan, MD, and FRCSC or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://podcastplayer.com/legal.

Dr. Regillo describes the results of the phase 3 prospective study of Ranibizumab Port Delivery System (PDS) for the treatment of neovascular AMD.

Reference Article:

Regillo C, Berger B, Brooks L, Clark WL, Mittra R, Wykoff CC, Callaway NF, DeGraaf S, Ding HT, Fung AE, Gune S, Le Pogam S, Smith R, Willis JR, Barteselli G. Archway Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration 2-Year Results. Ophthalmology. 2023 Jul;130(7):735-747. doi: 10.1016/j.ophtha.2023.02.024. Epub 2023 Mar 2. PMID: 36870451.

  continue reading

89 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play